- Home
- MPLN vs SRTS Comparison
MPLN vs SRTS Comparison
Compare MPLN & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLN
- SRTS
- Stock Information
- Founded
- MPLN 1980
- SRTS 2010
- Country
- MPLN United States
- SRTS United States
- Employees
- MPLN N/A
- SRTS N/A
- Industry
- MPLN Business Services
- SRTS Medical/Dental Instruments
- Sector
- MPLN Consumer Discretionary
- SRTS Health Care
- Exchange
- MPLN Nasdaq
- SRTS Nasdaq
- Market Cap
- MPLN 99.9M
- SRTS 106.0M
- IPO Year
- MPLN N/A
- SRTS 2016
- Fundamental
- Price
- MPLN $7.00
- SRTS $8.89
- Analyst Decision
- MPLN Hold
- SRTS Strong Buy
- Analyst Count
- MPLN 2
- SRTS 2
- Target Price
- MPLN $25.00
- SRTS $12.50
- AVG Volume (30 Days)
- MPLN 84.7K
- SRTS 262.3K
- Earning Date
- MPLN 11-05-2024
- SRTS 11-14-2024
- Dividend Yield
- MPLN N/A
- SRTS N/A
- EPS Growth
- MPLN N/A
- SRTS N/A
- EPS
- MPLN N/A
- SRTS 0.57
- Revenue
- MPLN $942,614,000.00
- SRTS $41,308,000.00
- Revenue This Year
- MPLN N/A
- SRTS $55.14
- Revenue Next Year
- MPLN $1.07
- SRTS $21.75
- P/E Ratio
- MPLN N/A
- SRTS $15.62
- Revenue Growth
- MPLN N/A
- SRTS 65.62
- 52 Week Low
- MPLN $4.80
- SRTS $2.05
- 52 Week High
- MPLN $69.20
- SRTS $9.20
- Technical
- Relative Strength Index (RSI)
- MPLN 41.66
- SRTS 75.94
- Support Level
- MPLN $4.80
- SRTS $6.70
- Resistance Level
- MPLN $9.15
- SRTS $9.20
- Average True Range (ATR)
- MPLN 0.91
- SRTS 0.56
- MACD
- MPLN -0.14
- SRTS 0.21
- Stochastic Oscillator
- MPLN 49.89
- SRTS 89.08
About MPLN MultiPlan Corporation
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.